PFG Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-9,306
| Closed | -$317K | – | 603 |
|
2023
Q2 | $317K | Sell |
9,306
-1,639
| -15% | -$55.9K | 0.02% | 506 |
|
2023
Q1 | $329K | Buy |
10,945
+18
| +0.2% | +$541 | 0.03% | 467 |
|
2022
Q4 | $308K | Sell |
10,927
-798
| -7% | -$22.5K | 0.03% | 446 |
|
2022
Q3 | $385K | Sell |
11,725
-2,711
| -19% | -$89K | 0.04% | 366 |
|
2022
Q2 | $455K | Sell |
14,436
-25,184
| -64% | -$794K | 0.05% | 260 |
|
2022
Q1 | $1.82M | Sell |
39,620
-10,909
| -22% | -$501K | 0.18% | 123 |
|
2021
Q4 | $3.09M | Sell |
50,529
-10,500
| -17% | -$643K | 0.3% | 85 |
|
2021
Q3 | $4.56M | Buy |
61,029
+4,003
| +7% | +$299K | 0.5% | 37 |
|
2021
Q2 | $5.28M | Buy |
57,026
+12,216
| +27% | +$1.13M | 0.6% | 29 |
|
2021
Q1 | $3.98M | Buy |
44,810
+14,144
| +46% | +$1.26M | 0.51% | 41 |
|
2020
Q4 | $2.86M | Buy |
30,666
+15,582
| +103% | +$1.45M | 0.48% | 52 |
|
2020
Q3 | $1.06M | Buy |
15,084
+1,374
| +10% | +$96.5K | 0.2% | 131 |
|
2020
Q2 | $764K | Buy |
13,710
+1,716
| +14% | +$95.6K | 0.17% | 151 |
|
2020
Q1 | $463K | Buy |
+11,994
| New | +$463K | 0.12% | 183 |
|